Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

OPKO Health

Biotech & Life Sciences · Miami, United States · Founded 2007 · IPO 2007 Unicorn

Developing proprietary versions of proteins already approved for medical therapy

Valuation
$908M
Market cap · May/2026
Revenue
$607M
Latest reported FY

Global footprint

Where OPKO Health has talent and traffic

Workforce by country
11 countries with
team presence
🇺🇸 United States64.3%
🇨🇱 Chile16.8%
🇲🇽 Mexico12.6%
🇪🇸 Spain2.2%
🇨🇦 Canada1.1%
Top 5 of 11 shown
Web traffic by country
8.1K monthly visits
across markets
🇺🇸 United States86.4%
🇮🇳 India24.7%
🇮🇱 Israel8.6%
🇩🇪 Germany2.5%
🇪🇸 Spain1.2%
Top 5 markets shown

Patent intelligence

$296M patent portfolio · 85 active families

Estimated portfolio value
$296M
32.5% of market cap · comparable to top peer Galapagos ($230M)
85 active patent families
Where OPKO Health innovates Pharmaceutical drugDosage formDiseaseFluid systemMicro fluidic

Where OPKO Health concentrates vs peers

Each axis is a top-10 topic across OPKO Health and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Capital deployed

OPKO Health's 10 investments and acquisitions.

Every disclosed deal where OPKO Health appeared as a backer or acquirer, 2010–2022. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

10 deals across OPKO Health's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        01 · Deployment strategy vs peers

        Where OPKO Health deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        02 · Portfolio market map

        OPKO Health's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        10 of 10 deals

        Market sentiment

        What the market is saying about OPKO Health

        An AI-synthesized read of the highest-engagement posts about OPKO Health on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See OPKO Health on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.